)
Visual24 Oct 2025
The rise of Alphabet
Dyadic International (DYAI) investor relations material
Dyadic International Small-Cap Virtual Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Small-Cap Virtual Conference summary18 Sep, 2025
Strategic transformation and market focus
Shifted from a platform-based, R&D-focused organization to a product-driven, revenue-focused company targeting high-growth, non-therapeutic markets.
Rebranded and restructured to prioritize faster, more reliable revenue streams in life sciences, food, nutrition, and bioindustrial sectors.
Platforms C1 and Dapibus now validated and commercial, supporting high-yield, animal-free recombinant protein production.
Biopharmaceutical programs moved to legacy, externally funded status, freeing resources for non-therapeutic commercialization.
Partnerships with Proliant, Enzymes, and Fermbox Bio drive market entry and revenue across all verticals.
Product pipeline and commercialization
Initial revenues from partnerships and product launches expected in 2024–2025, with recurring revenues ramping up by 2026–2027.
Key products include recombinant albumin, transferrin, growth factors, DNase I, and non-animal dairy enzymes.
Multiple monetization strategies: licensing, strategic partnerships, and direct product sales, enabling recurring revenue streams.
Time to market for new products reduced to under a year, significantly faster than traditional biopharma timelines.
Pipeline includes cross-segment products, such as alpha-lactalbumin, with applications in both food and life sciences.
Market opportunities and financial outlook
Addressable market estimated at $25 billion across targeted segments.
Life sciences focus on cell culture media, diagnostics, and molecular biology reagents; food and nutrition targets non-animal dairy and functional proteins; bioindustrial targets enzymes for biomass, pulp, and textiles.
Partnerships enable rapid scaling, with a 50-50 profit share in bioindustrial via Fermbox Bio.
Low annual burn rate ($4–5 million); forecast to be cash flow positive by end of 2026, with profitability expected within three years.
High-value partnerships and externally funded legacy programs (e.g., Gates Foundation, European Vaccine Hub) provide non-dilutive funding and strategic validation.
How will key product launches scale by 2026?
What specific advantages drive market penetration?
How are internal resources managed for biopharma?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Dyadic International earnings date
Q3 202512 Nov, 2025
Next Dyadic International earnings date
Q3 202512 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Dyadic International Inc. is a biotechnology company specializing in the development and commercialization of technologies for gene expression and protein production. The company’s primary platform, the C1 gene expression system, is used to produce enzymes and proteins for various industries, including biopharmaceuticals, vaccines, and industrial applications. Dyadic focuses on leveraging its proprietary technology to accelerate the development of biologics and other biotechnological products, aiming to improve production efficiency and scalability. The company is headquartered in Jupiter, Florida, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage